Common Cold
📧 Sign up to get email alerts when something new happens for Common Cold.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections [Phase 3]
Phase 3 trial completed evaluating post-exposure prophylaxis with Ingavirin for influenza and acute respiratory viral infections.
-
FDA approval · 2017-06-09FDA Approved: PSEUDOEPHEDRINE HCL — Original Application (Better Living Brands LLC)
FDA approved the original ANDA for pseudoephedrine HCl (Better Living Brands LLC), authorizing its marketing as an over-the-counter nasal de…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults [Phase 4]
A Phase 4 trial evaluated the efficacy and safety of Ingavirin 90 mg once daily for influenza and other acute viral infections in adults and…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Efficacy and Safety of Imuneks 10 mg Capsules in the Prophylaxis of Cold [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Imuneks 10 mg capsules for prophylaxis of cold symptoms has completed.
-
FDA approval · 2017-04-28FDA Approved: ADVIL ALLERGY AND CONGESTION RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for ADVIL ALLERGY AND CONGESTION RELIEF, a combination product containing chlorpheniramine maleate, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR) [NA]
This clinical trial update summarizes results from a study evaluating whether a probiotic modulates the host immune response to rhinovirus i…
-
FDA label_change · 2017-03-24FDA Approved: ADVIL ALLERGY SINUS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application to update the labeling for ADVIL ALLERGY SINUS, a three-drug combination (chlorpheniramine maleate, …
-
FDA approval · 2017-03-24FDA Approved: ADVIL SINUS CONGESTION AND PAIN — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application to market Advil Sinus Congestion and Pain, a combination ibuprofen and phenylephrine product fro…
-
FDA approval · 2017-03-24FDA Approved: ADVIL ALLERGY AND CONGESTION RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Advil Allergy and Congestion Relief, a combination product containing chlorpheniramine maleate, …
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Efficacy and Safety of Regan Tangjiang for Treating the Common Cold With Wind-heat Syndrome [Phase 2]
Phase 2 clinical trial update evaluating the efficacy and safety of Regan Tangjiang for the common cold with wind-heat syndrome.
-
FDA label_change · 2017-03-24FDA Approved: ADVIL COLD AND SINUS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental labeling application for Advil Cold and Sinus, a combination product of ibuprofen and pseudoephedrine hydrochlor…
-
FDA approval · 2017-03-23FDA Approved: ADVIL COLD AND SINUS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Advil Cold and Sinus, a combination product of ibuprofen and pseudoephedrine hydrochloride. The …
-
FDA approval · 2017-03-17FDA Approved: MUCUS RELIEF DM MAXIMUM STRENGTH — Original Application (Better Living Brands LLC)
The FDA approved the original ANDA for MUCUS RELIEF DM MAXIMUM STRENGTH, a combination product of guaifenesin and dextromethorphan hydrobrom…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough [Phase 3]
A Phase 3 trial update reports results on the tolerability and warming sensation of acetylcysteine 2% oral solution for productive cough in …
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of a paracetamol/dimethindene maleate/phenylephrine hydrochloride combination tablet for …
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides) [Phase 3]
Phase 3 study evaluating the safety and intake of EPs 7630, a Pelargonium sidoides root extract, for the common cold; the trial has complete…
-
CLINICAL_TRIALS withdrawal · 2016-10-19Clinical Trial Update: Study Comparing 3 Formulations to Evaluate the Efficacy and Safety of the Inflammatory Symptoms of the Upper Respiratory Tract, in Children Between 2 and 6 Years Old [Phase 3]
A Phase 3 trial evaluating three formulations for inflammatory symptoms of the upper respiratory tract in children aged 2 to 6 has been with…
-
FDA approval · 2016-09-20FDA Approved: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE — Original Application (Acella Pharmaceuticals, LLC)
FDA approved an original application for a generic combination product containing brompheniramine maleate, pseudoephedrine hydrochloride, an…
-
FDA approval · 2016-08-25FDA Approved: TUXARIN — Supplemental Application (Mainpointe Pharmaceuticals)
FDA approved a supplemental application for TUXARIN (codeine phosphate and chlorpheniramine maleate) from Mainpointe Pharmaceuticals. The ap…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough [Phase 2]
Phase 2 trial evaluating N-acetylcysteine (NAC) for the treatment of the common cold with cough has completed, with results posted on 2016-0…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Nasal Swab Study to Explore the Nasal Microbia
Clinical trial update indicates the nasal swab study exploring the nasal microbiota in the context of the Common Cold has completed. The spo…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza. [Phase 4]
Phase 4 trial evaluating an over-the-counter combination tablet (paracetamol, pseudoephedrine hydrochloride, dextromethorphan hydrobromide, …
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o. [Phase 3]
This update reports the completion of a Phase 3 trial evaluating the efficacy and safety of Ingavirin for influenza and other acute respirat…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold [Phase 3]
A multicenter Phase 3 trial evaluating pseudoephedrine for temporary relief of nasal congestion in children with the common cold has complet…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold [Phase 3]
Phase 3 clinical trial comparing Coristina D to Resfenol for symptomatic treatment of the common cold is underway.